Dr. Hönle AG (HNL) - Net Assets
Based on the latest financial reports, Dr. Hönle AG (HNL) has net assets worth €77.03 Million EUR (≈ $90.06 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€145.52 Million ≈ $170.12 Million USD) and total liabilities (€68.48 Million ≈ $80.06 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check HNL financial resilience to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €77.03 Million |
| % of Total Assets | 52.94% |
| Annual Growth Rate | 4.06% |
| 5-Year Change | -30.68% |
| 10-Year Change | 24.91% |
| Growth Volatility | 13.98 |
Dr. Hönle AG - Net Assets Trend (2014–2025)
This chart illustrates how Dr. Hönle AG's net assets have evolved over time, based on quarterly financial data. Also explore HNL current and non-current assets for the complete picture of this company's asset base.
Annual Net Assets for Dr. Hönle AG (2014–2025)
The table below shows the annual net assets of Dr. Hönle AG from 2014 to 2025. For live valuation and market cap data, see HNL company net worth.
| Year | Net Assets | Change |
|---|---|---|
| 2025-09-30 | €77.03 Million ≈ $90.06 Million |
-3.33% |
| 2024-09-30 | €79.69 Million ≈ $93.16 Million |
-17.11% |
| 2023-09-30 | €96.13 Million ≈ $112.39 Million |
-10.36% |
| 2022-09-30 | €107.24 Million ≈ $125.37 Million |
-3.50% |
| 2021-09-30 | €111.12 Million ≈ $129.91 Million |
-4.77% |
| 2020-09-30 | €116.69 Million ≈ $136.42 Million |
+29.47% |
| 2019-09-30 | €90.12 Million ≈ $105.36 Million |
+3.29% |
| 2018-09-30 | €87.25 Million ≈ $102.00 Million |
+25.04% |
| 2017-09-30 | €69.78 Million ≈ $81.58 Million |
+13.15% |
| 2016-09-30 | €61.67 Million ≈ $72.10 Million |
+7.22% |
| 2015-09-30 | €57.51 Million ≈ $67.24 Million |
+15.68% |
| 2014-09-30 | €49.72 Million ≈ $58.13 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Dr. Hönle AG's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 13.1% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (September 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | €28.83 Million | 37.51% |
| Other Components | €48.03 Million | 62.49% |
| Total Equity | €76.87 Million | 100.00% |
Dr. Hönle AG Competitors by Market Cap
The table below lists competitors of Dr. Hönle AG ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Power Metals Corp
V:PWM
|
$52.67 Million |
|
Sam Jung Pulp
KO:009770
|
$52.69 Million |
|
Acrivon Therapeutics, Inc. Common Stock
NASDAQ:ACRV
|
$52.70 Million |
|
Mr Bricolage
PA:ALMRB
|
$52.71 Million |
|
Plus Therapeutics Inc
NASDAQ:PSTV
|
$52.66 Million |
|
BranchOut Food Inc. Common Stock
NASDAQ:BOF
|
$52.64 Million |
|
Toivo Group Oyj
HE:TOIVO
|
$52.62 Million |
|
Voksel Electric Tbk
JK:VOKS
|
$52.60 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Dr. Hönle AG's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 79,420,000 to 76,867,000, a change of -2,553,000 (-3.2%).
- Net loss of 3,168,000 reduced equity.
- Dividend payments of 128,000 reduced retained earnings.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €-3.17 Million | -4.12% |
| Dividends Paid | €128.00K | -0.17% |
| Other Changes | €743.00K | +0.97% |
| Total Change | €- | -3.21% |
Book Value vs Market Value Analysis
This analysis compares Dr. Hönle AG's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.69x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-09-30 | €12.32 | €8.74 | x |
| 2018-09-30 | €15.80 | €8.74 | x |
| 2019-09-30 | €16.32 | €8.74 | x |
| 2020-09-30 | €19.19 | €8.74 | x |
| 2021-09-30 | €18.26 | €8.74 | x |
| 2022-09-30 | €17.63 | €8.74 | x |
| 2023-09-30 | €15.81 | €8.74 | x |
| 2024-09-30 | €13.10 | €8.74 | x |
| 2025-09-30 | €12.68 | €8.74 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Dr. Hönle AG utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -4.12%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -3.38%
- • Asset Turnover: 0.64x
- • Equity Multiplier: 1.89x
- Recent ROE (-4.12%) is below the historical average (4.58%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2014 | 13.15% | 7.59% | 0.96x | 1.80x | €1.50 Million |
| 2015 | 18.13% | 10.95% | 1.02x | 1.63x | €4.54 Million |
| 2016 | 13.83% | 8.86% | 0.99x | 1.57x | €2.29 Million |
| 2017 | 15.36% | 10.23% | 1.00x | 1.51x | €3.64 Million |
| 2018 | 24.96% | 17.19% | 1.01x | 1.44x | €13.03 Million |
| 2019 | 13.87% | 11.58% | 0.75x | 1.60x | €3.48 Million |
| 2020 | 4.88% | 6.05% | 0.48x | 1.69x | €-5.96 Million |
| 2021 | -4.35% | -4.19% | 0.57x | 1.83x | €-15.89 Million |
| 2022 | -12.50% | -10.56% | 0.65x | 1.83x | €-24.05 Million |
| 2023 | -11.49% | -10.35% | 0.60x | 1.84x | €-20.59 Million |
| 2024 | -16.72% | -13.45% | 0.64x | 1.96x | €-21.22 Million |
| 2025 | -4.12% | -3.38% | 0.64x | 1.89x | €-10.85 Million |
Industry Comparison
This section compares Dr. Hönle AG's net assets metrics with peer companies in the Electrical Equipment & Parts industry.
Industry Context
- Industry: Electrical Equipment & Parts
- Average net assets among peers: $9,329,607,425
- Average return on equity (ROE) among peers: -3.93%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Dr. Hönle AG (HNL) | €77.03 Million | 13.15% | 0.89x | $52.66 Million |
| Leoch International Technology Limited (0LT) | $3.05 Billion | 7.97% | 1.83x | $111.14 Million |
| Plejd AB (publ) (3CA) | $129.50 Million | 0.20% | 0.22x | $925.60 Million |
| ENDURANCE MOTIVE EO -02 (7VB) | $1.06 Million | -28.20% | 5.21x | $37.78 Million |
| CBAK ENERGY TECH. NEW (B6JA) | $140.88 Million | 43.64% | 0.86x | $61.13 Million |
| MERSEN UNSP.ADR 1/5 EO 2 (CBE0) | $631.40 Million | 8.62% | 1.05x | $566.93 Million |
| FRIWO AG (CEA) | $17.65 Million | 22.88% | 2.27x | $43.21 Million |
| Delta Electronics (Thailand) Public Company Limited (DLS) | $79.94 Billion | 23.69% | 0.54x | $91.81K |
| SFC Energy AG (F3C) | $51.91 Million | 0.00% | 0.15x | $254.36 Million |
| Lightbridge Corporation (N7ON) | $5.56 Million | -114.17% | 0.22x | $359.97 Million |
About Dr. Hönle AG
Hoenle AG develops, manufactures, and distributes industrial UV technologies and systems in Germany and internationally. It operates through three segments: Adhesive Systems, Curing, and Disinfection. The Adhesives Systems segment offers industrial adhesives, as well as supplies adhesive curing systems used for consumer electronics, automotive, optics and opto-electronics, and curing of adhesives… Read more